Pediatric pulmonary veno-occlusive disease associated with a novel BMPR2 variant.


Journal

Pediatric pulmonology
ISSN: 1099-0496
Titre abrégé: Pediatr Pulmonol
Pays: United States
ID NLM: 8510590

Informations de publication

Date de publication:
05 2022
Historique:
revised: 17 02 2022
received: 28 09 2021
accepted: 20 02 2022
pubmed: 2 3 2022
medline: 22 4 2022
entrez: 1 3 2022
Statut: ppublish

Résumé

Pulmonary veno-occlusive disease (PVOD) and idiopathic/heritable pulmonary arterial hypertension (I/HPAH) cause progressive PH on the distinct genetic impact. A 29-month-old boy presented with a loss of consciousness. He had severe PH refractory to pulmonary vasodilators. Hypoxemia and ground-glass opacity on the chest computed tomography were present, and significant pulmonary edema developed after the introduction of continuous intravenous prostaglandin I

Identifiants

pubmed: 35229499
doi: 10.1002/ppul.25877
doi:

Substances chimiques

BMPR2 protein, human EC 2.7.11.30
Bone Morphogenetic Protein Receptors, Type II EC 2.7.11.30

Types de publication

Letter

Langues

eng

Sous-ensembles de citation

IM

Pagination

1366-1369

Informations de copyright

© 2022 Wiley Periodicals LLC.

Références

Montani D, Achouh L, Dorfmüller P, et al. Pulmonary veno-occlusive disease: clinical, functional, radiologic, and hemodynamic characteristics and outcome of 24 cases confirmed by histology. Medicine (Baltimore). 2008;87(4):220-233.
Gräf S, Haimel M, Bleda M, et al. Identification of rare sequence variation underlying heritable pulmonary arterial hypertension. Nat Commun. 2018;9(1):1416.
Oriaku I, LeSieur MN, Nichols WC, et al. A novel BMPR2 mutation with widely disparate heritable pulmonary arterial hypertension clinical phenotype. Pulm Circ. 2020;10(3):2045894020931315.
Eyries M, Montani D, Nadaud S, et al. Widening the landscape of heritable pulmonary hypertension mutations in paediatric and adult cases. Eur Respir J. 2019;53(3):1801371.
Ogawa A, Takahashi Y, Matsubara H. Clinical prediction score for identifying patients with pulmonary veno-occlusive disease/pulmonary capillary hemangiomatosis. J Cardiol. 2018;72(3):255-260.
Pousada G, Lupo V, Cástro-Sánchez S, et al. Molecular and functional characterization of the BMPR2 gene in pulmonary arterial hypertension. Sci Rep. 2017;7(1):1923.
Runo JR, Vnencak-Jones CL, Prince M, et al. Pulmonary veno-occlusive disease caused by an inherited mutation in bone morphogenetic protein receptor II. Am J Respir Crit Care Med. 2003;167(6):889-894.
Takahashi K, Chen F, Ikeda T, et al. Single-lobe lung transplantation for rapidly deteriorating pulmonary venoocclusive disease. Ann Thorac Surg. 2013;95(2):689-691.

Auteurs

Wataru Takemori (W)

Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Kenichiro Yamamura (K)

Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Department of Perinatal and Pediatric Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Yoshitaka Tomita (Y)

Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Naoki Egami (N)

Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Katsuhide Eguchi (K)

Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Hazumu Nagata (H)

Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Hiromitsu Shirouzu (H)

Department of Cardiology, Fukuoka Children's Hospital, Fukuoka, Japan.

Yuichi Ishikawa (Y)

Department of Cardiology, Fukuoka Children's Hospital, Fukuoka, Japan.

Daisuke Nakajima (D)

Department of Thoracic Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan.

Akihiko Yoshizawa (A)

Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan.

Hiroshi Date (H)

Department of Thoracic Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan.

Shouichi Ohga (S)

Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH